Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Cusi

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Journal of Hypertension|May 23, 2002
The strange behaviour of digitalis-like substancesDaniele Cusi
Journal of Hypertension|July 11, 2007
Context dependency of the salt intake: left ventricular hypertrophy connectionFabio Macciardi, Daniele Cusi
Journal of Hypertension|August 27, 2002
The time-honoured Galilean method and genetic association studies: the importance of hypothesis-driven selection of intermediate phenotypes in detecting genes associated to hypertensionDaniele Cusi, Maria Vittoria Taglietti
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 12, 2010
[Anticoagulant therapy in patients with atrial fibrillation on dialysis: between the risk of hemorrhage and vascular calcification]Mario Cozzolino, Chiara Ronga, Daniele Cusi
Journal of Hypertension|September 26, 2003
Angiotensinogen gene polymorphism, again?Daniele Cusi, Fabio Macciardi, Cristina Barlassina
Journal of Nephrology|December 31, 2003
Genetics of human arterial hypertensionDaniele Cusi, Cristina Barlassina, Maria Vittoria Taglietti
Nature Clinical Practice. Nephrology|December 22, 2006
Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockadeLucia Del Vecchio, Mirella Procaccio, Sara ViganĂ², et al.
Recenti Progressi in Medicina|May 4, 2010
[Renal effects of combined anti-hypertensive treatments]Maurizio Gallieni, Laura Olivi, Nicoletta Mezzina, et al.
Seminars in Nephrology|February 28, 2012
Role of vitamin d receptor activators in cardio-renal syndromesMario Cozzolino, Elena Bruschetta, Andrea Stucchi, et al.
Therapeutic Advances in Chronic Disease|December 20, 2012
Sevelamer for hyperphosphataemia in kidney failure: controversy and perspectiveMario Cozzolino, Maria Antonietta Rizzo, Andrea Stucchi, et al.
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Journal of Hypertension|May 23, 2002
The strange behaviour of digitalis-like substancesDaniele Cusi
Journal of Hypertension|July 11, 2007
Context dependency of the salt intake: left ventricular hypertrophy connectionFabio Macciardi, Daniele Cusi
Journal of Hypertension|August 27, 2002
The time-honoured Galilean method and genetic association studies: the importance of hypothesis-driven selection of intermediate phenotypes in detecting genes associated to hypertensionDaniele Cusi, Maria Vittoria Taglietti
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 12, 2010
[Anticoagulant therapy in patients with atrial fibrillation on dialysis: between the risk of hemorrhage and vascular calcification]Mario Cozzolino, Chiara Ronga, Daniele Cusi
Journal of Hypertension|September 26, 2003
Angiotensinogen gene polymorphism, again?Daniele Cusi, Fabio Macciardi, Cristina Barlassina
Journal of Nephrology|December 31, 2003
Genetics of human arterial hypertensionDaniele Cusi, Cristina Barlassina, Maria Vittoria Taglietti
Nature Clinical Practice. Nephrology|December 22, 2006
Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockadeLucia Del Vecchio, Mirella Procaccio, Sara ViganĂ², et al.
Recenti Progressi in Medicina|May 4, 2010
[Renal effects of combined anti-hypertensive treatments]Maurizio Gallieni, Laura Olivi, Nicoletta Mezzina, et al.
Seminars in Nephrology|February 28, 2012
Role of vitamin d receptor activators in cardio-renal syndromesMario Cozzolino, Elena Bruschetta, Andrea Stucchi, et al.
Therapeutic Advances in Chronic Disease|December 20, 2012
Sevelamer for hyperphosphataemia in kidney failure: controversy and perspectiveMario Cozzolino, Maria Antonietta Rizzo, Andrea Stucchi, et al.
Pageof 15